Skip to main content
. 2023 May 27;15(5):688–698. doi: 10.4254/wjh.v15.i5.688

Table 2.

Diagnosis and background of the studied groups, n (%)

Group

Variables
GTMI (n = 21)
CG (n = 20)
Total (n = 41)
P value
Diagnostics
Liver metastasis 9 (42.9) 8 (40.0) 17 (41.5)
Hepatocellular carcinoma 8 (38.1) 3 (15.0) 11 (26.8)
Hepatic nodule 3 (14.3) 4 (20.0) 7 (17.1)
Cholangiocarcinoma 1 (4.8) 4 (20.0) 5 (12.2)
Hemangioma 0 (0.0) 1 (5.0) 1 (2.4) -
Background
Hepatic cirrhosis
No 15 (71.4) 18 (90.0) 33 (80.5)
Yes 6 (28.6) 2 (10.0) 8 (19.5) 0.23792
Hepatitis C
No 17 (81.0) 18 (90.0) 35 (85.4)
Yes 4 (19.0) 2 (10.0) 6 (14.6) 0.66282
Previous neoplasm
No 10 (47.6) 8 (40.0) 18 (43.9)
Yes 11 (52.4) 12 (60.0) 23 (56.1) 0.62321
Chemotherapy
No 12 (57.1) 13 (65.0) 25 (61.0)
Yes 9 (42.9) 7 (35.0) 16 (39.0) 0.60621
Smoker/former smoker
No 15 (71.4) 18 (90.0) 33 (80.5)
Yes 6 (28.6) 2 (10.0) 8 (19.5) 0.23792
1

Based on the chi-square test.

2

Based on Fisher's exact test.

GTMI: Inspiratory muscle training group; CG: Control group.